Antistolling
Population-beased research in myelodysplastic syndrome
- Universiteit Rijksuniversiteit Groningen
- Promovendus Hanne Rozema
- Promoters Eric van Roon
- Co-Promoters Mels Hoogendoorn Robby Kibbelaar
- Jaar 2018 - 2022
Drug repositioning is the application of existing drugs to new indications. We want to find out if it is possible to find new potentially effective drugs against individual tumors based on their unique gene expression patterns.
Het doel van dit onderzoek is de behandeling van longkanker verder te individualiseren en vroeg in de therapie te kunnen voorspellen wie reageert op immunotherapie.